Eris Lifesciences Ltd banner

Eris Lifesciences Ltd
NSE:ERIS

Watchlist Manager
Eris Lifesciences Ltd Logo
Eris Lifesciences Ltd
NSE:ERIS
Watchlist
Price: 1 360.4 INR 0.15% Market Closed
Market Cap: ₹188.4B

Wall Street
Price Targets

ERIS Price Targets Summary
Eris Lifesciences Ltd

Wall Street analysts forecast ERIS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ERIS is 1 789.9 INR with a low forecast of 1 535.2 INR and a high forecast of 2 037 INR.

Lowest
Price Target
1 535.2 INR
13% Upside
Average
Price Target
1 789.9 INR
32% Upside
Highest
Price Target
2 037 INR
50% Upside
Eris Lifesciences Ltd Competitors:
Price Targets

Revenue
Forecast

18% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
18% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 12 years the compound annual growth rate for Eris Lifesciences Ltd's revenue is 18%. The projected CAGR for the next 3 years is 15%.

Operating Income
Forecast

20% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
20% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 12 years the compound annual growth rate for Eris Lifesciences Ltd's operating income is 20%. The projected CAGR for the next 3 years is 22%.

Net Income
Forecast

16% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
16% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 12 years the compound annual growth rate for Eris Lifesciences Ltd's net income is 16%. The projected CAGR for the next 3 years is 39%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ERIS's stock price target?
Price Target
1 789.9 INR

According to Wall Street analysts, the average 1-year price target for ERIS is 1 789.9 INR with a low forecast of 1 535.2 INR and a high forecast of 2 037 INR.

What is Eris Lifesciences Ltd's Revenue forecast?
Projected CAGR
15%

For the last 12 years the compound annual growth rate for Eris Lifesciences Ltd's revenue is 18%. The projected CAGR for the next 3 years is 15%.

What is Eris Lifesciences Ltd's Operating Income forecast?
Projected CAGR
22%

For the last 12 years the compound annual growth rate for Eris Lifesciences Ltd's operating income is 20%. The projected CAGR for the next 3 years is 22%.

What is Eris Lifesciences Ltd's Net Income forecast?
Projected CAGR
39%

For the last 12 years the compound annual growth rate for Eris Lifesciences Ltd's net income is 16%. The projected CAGR for the next 3 years is 39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett